You are here

16th Annual Meeting of the North American Menopause Society

Lawrence M. Prescott, PhD, and Sharon L. Prescott
PDF version: 
The Prescotts discuss hormonal replacement therapy; lasofoxifene for vaginal atrophy; testosterone for low libido; alendronate, transdermal estrogen, risedronate, and ibandronate for osteoporosis; and the transdermal oxybutynin patch for overactive bladder.